{"organizations": ["GlaxoSmithKline", "AstraZeneca"], "uuid": "92b9a7e6d69e18a6acfb72774735da6c7360fb2f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.finance.yahoo.com", "main_image": "https://s1.yimg.com/bt/api/res/1.2/M7vS95b2fvSzHFeFStPk0A--/YXBwaWQ9eW5ld3NfbGVnbztxPTc1O3c9NjAw/http://l.yimg.com/os/mit/media/m/social/images/social_default_logo-1481777.png", "site_section": "https://uk.finance.yahoo.com/news/sector-health-care/?format=rss", "section_title": "Health Care News | Pharmaceutical News - Yahoo! Finance UK", "url": "https://uk.finance.yahoo.com/news/number-one-difference-between-glaxosmithkline-105958165.html", "country": "US", "title": "What’s The Number One Difference Between GlaxoSmithKline plc And AstraZeneca plc?", "performance_score": 0, "site": "yahoo.com", "participants_count": 0, "title_full": "What’s The Number One Difference Between GlaxoSmithKline plc And AstraZeneca plc?", "spam_score": 0.0, "site_type": "news", "published": "2015-09-21T13:59:00.000+03:00", "replies_count": 0, "uuid": "92b9a7e6d69e18a6acfb72774735da6c7360fb2f"}, "author": "", "url": "https://uk.finance.yahoo.com/news/number-one-difference-between-glaxosmithkline-105958165.html", "ord_in_thread": 0, "title": "What’s The Number One Difference Between GlaxoSmithKline plc And AstraZeneca plc?", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Tip : Use comma (,) to separate multiple quotes. Learn more... \nTue, Sep 22, 2015, 01:29 BST - UK Markets open in 6 hrs 31 mins What’s The Number One Difference Between GlaxoSmithKline plc And AstraZeneca plc? By Owain Bennallack | Fool.co.uk – 13 hours ago 1,289.50 +4.50 \nInvestors often lump similar companies from the same sector together, and as a first pass at categorizing the thousands of companies out there, that's understandable. However a closer look under the hood of drugs giants GlaxoSmithKline (LSE: GSK)) and AstraZeneca (LSE: AZN) reveals two different strategies at play. \nA video or other embedded content has been hidden. Click here to view it. \nOur top analysts have highlighted five top shares in the FTSE 100 in our special free report \" 5 Shares To Retire On \". To find out the names of the shares and the reasons behind their inclusion, simply click here to view it immediately with no obligations whatsoever. \n\nOwain Bennallack has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.", "external_links": [], "published": "2015-09-21T13:59:00.000+03:00", "crawled": "2015-09-22T03:41:09.500+03:00", "highlightTitle": ""}